<i>RAS</i> Mutations Are Associated With the Development of Cutaneous Squamous Cell Tumors in Patients Treated With RAF Inhibitors

Patrick A. Oberholzer(Sanofi (United States)), Levi A. Garraway(Broad Institute)
Journal of Clinical Oncology
November 8, 2011
Cited by 381


Related Papers